Stock ATOSSA GENETICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Editorial Features Atossa Genetics Inc Nasdaq

Equities

US04962H1005

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Atossa Genetics Inc
05-15 Atossa Therapeutics Doses Last Patient in Phase 2 Karisma-Endoxifen Trial MT
05-15 Atossa Therapeutics, Inc. Announces Last Patient, Last Dose in Its Phase 2 Karisma-Endoxifen Clinical Trial CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATOS Stock
  4. Stock
  5. News Atossa Genetics Inc
  6. MarketScreener Editorial Features